Two-Drug attack on deadly melanoma in the brain
NCT ID NCT03873818
Summary
This study tested a combination of two immunotherapy drugs, ipilimumab and pembrolizumab, in patients whose melanoma had spread to their brain. The goal was to see if using a lower dose of ipilimumab with pembrolizumab was safe and could help control the cancer in the brain. The trial included 24 patients who had not yet received certain other immunotherapies for their advanced cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM IN THE BRAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.